about
Stimulating healthy tissue regeneration by targeting the 5-HT₂B receptor in chronic liver disease.Evaluation of imatinib mesylate in the treatment of pulmonary arterial hypertension.The interaction between endothelin-1 and nitric oxide in the vasculature: new perspectives.Review of companies and drug classes in the 2007-2011 antihypertensive patent literature.Advances in treatment of pulmonary arterial hypertension: patent review.Activated hepatic stellate cells: negative regulators of hepatocyte proliferation in liver diseases
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Leads for the treatment of pulmonary hypertension.
@en
Leads for the treatment of pulmonary hypertension.
@nl
type
label
Leads for the treatment of pulmonary hypertension.
@en
Leads for the treatment of pulmonary hypertension.
@nl
prefLabel
Leads for the treatment of pulmonary hypertension.
@en
Leads for the treatment of pulmonary hypertension.
@nl
P2860
P1476
Leads for the treatment of pulmonary hypertension.
@en
P2093
Michael J Palmer
P2860
P304
P356
10.1517/13543770902877725
P407
P577
2009-05-01T00:00:00Z